| Literature DB >> 36059300 |
Farah Naaz Kazi1, Shaurav Ghosh2, J V Pranav Sharma2, Shwetha Saravanan3, Sanjana Patil3.
Abstract
Millennials (age: 25-32 years) and Generation-Z individuals (age: 10-25 years) exhibit a shift in the occurrence of gallbladder diseases, which may be related to changes in lifestyle and genetics. In light of these findings, we performed a retrospective observational study on patients who underwent gallbladder surgeries to determine the trend in gallbladder diseases in young adults. Both categorical and continuous data on 90 patients were collected between January 2020 and June 2021 and analysed retrospectively, with differences considered significant at a p-value of 0.05. The diagnosis of gallstones in young adults is presently complicated, as the signs and symptoms of biliary tract sickness differ significantly between those under and over 30 years of age. We observed that gallbladder diseases and their complications were highly common in individuals between the ages of 21 and 25 years. We discovered that gallstones were more common in teenagers than previously thought. Delays in intervention resulted in future complications which could have been avoided.Entities:
Keywords: cholelithiasis; common bile duct; ercp; gall blader disease; young
Year: 2022 PMID: 36059300 PMCID: PMC9423860 DOI: 10.7759/cureus.28555
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Distribution of subjects according to age group
| Age distribution | Frequency(n) | Percent(%) |
| <20 years | 08 | 8.90 |
| 21-25 years | 31 | 34.40 |
| 26-30 years | 51 | 56.70 |
| Total | 90 | 100.00 |
Distribution of subjects according to sex
| Sex Distribution | Frequency(n) | Percent(%) |
| Female | 65 | 72.20 |
| Male | 25 | 7.80 |
| Total | 90 | 100.00 |
Distribution of subjects according to age and gallbladder pathologies
CBT: common bile duct, ERCP: endoscopic retrograde cholangiopancreatography, S/P: status post
| Gallbladder pathology | <20 years | 21–25 years | 26–30 years | |||
| n | % | n | % | n | % | |
| Acute calculous cholecystitis | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| Beta thalassemia with cholelithiasis | 1 | 12.50 | 0 | 0.00 | 0 | 0.00 |
| Calculous cholecystitis | 0 | 0.00 | 2 | 6.40 | 0 | 0.00 |
| Calculous cholelithiasis | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| Cholecystitis S/P partial cholecystectomy | 0 | 0.00 | 1 | 3.20 | 0 | 0.00 |
| Choledochal cyst other types | 0 | 0.00 | 0 | 0.00 | 2 | 3.90 |
| Choledochal cyst type 1 | 1 | 12.50 | 0 | 0.00 | 0 | 0.00 |
| Choledochal cyst type 4A | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| Cholelithiasis | 1 | 12.50 | 5 | 16.10 | 10 | 19.60 |
| Cholelithiasis with choledocholithiasis | 0 | 0.00 | 1 | 3.20 | 1 | 2.00 |
| Chronic calculous cholecystitis with pseudocyst of pancreas | 0 | 0.00 | 1 | 3.20 | 0 | 0.00 |
| Chronic calculous cholelithiasis | 0 | 0.00 | 4 | 12.90 | 5 | 9.80 |
| Chronic calculus cholecystitis | 0 | 0.00 | 12 | 38.70 | 21 | 41.20 |
| Chronic cholecystitis | 0 | 0.00 | 0 | 0.00 | 2 | 4.00 |
| Chronic cholelithiasis | 0 | 0.00 | 1 | 3.20 | 0 | 0.00 |
| Dilated CBD with cholelithiasis | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| Gall bladder polyp | 0 | 0.00 | 1 | 3.20 | 2 | 3.90 |
| Gall bladder sludge with chronic cholecystitis | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| Obstructive jaundice and calculi in the CBD | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| S/P cholecystectomy with discharging sinus over the scar | 0 | 0.00 | 1 | 3.20 | 0 | 0.00 |
| S/P ERCP for choledocholithiasis | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| S/P ERCP for choledocholithiasis with cholelithiasis | 0 | 0.00 | 1 | 3.20 | 0 | 0.00 |
| S/P ERCP with cholelithiasis | 0 | 0.00 | 0 | 0.00 | 1 | 2.00 |
| Splenomegaly and chronic cholecystitis | 0 | 0.00 | 1 | 3.20 | 0 | 0.00 |
| Type 4 choledochal cyst | 1 | 12.50 | 0 | 0.00 | 0 | 0.00 |
Distribution of subjects according to age and liver function tests (LFTs)
TB: total bilirubin, AST: aspartate aminotransferase, ALT: alanine transaminase, ALP: alkaline phosphatase
| AGE GROUP | TB | AST | ALT | ALP | |
| <20 years | Mean | 1.82 | 27.38 | 30.00 | 93.63 |
| SD | 2.37 | 8.14 | 16.49 | 25.59 | |
| 21-25 years | Mean | 1.22 | 55.32 | 68.06 | 121.39 |
| SD | 1.65 | 67.99 | 88.47 | 135.66 | |
| 26-30 years | Mean | 2.28 | 43.57 | 50.63 | 94.55 |
| SD | 7.24 | 73.41 | 64.43 | 90.85 | |
| Overall | Mean | 1.88 | 46.18 | 54.80 | 103.71 |
| SD | 5.57 | 68.24 | 71.54 | 105.16 | |
| P Value | 0.70 | 0.54 | 0.34 | 0.52 | |